Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Prostate Cancer AJCC v8”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00083005
What this trial is testing

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
National Institutes of Health Clinical Center (CC) 60
Testing effectiveness (Phase 2)Study completedNCT00045227
What this trial is testing

Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT02807805
What this trial is testing

Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
Mamta Parikh 37
Large-scale testing (Phase 3)Study completedNCT00104715
What this trial is testing

Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 385
Testing effectiveness (Phase 2)Study completedNCT00005810
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 40
Not applicableEnded earlyNCT00288106
What this trial is testing

S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 961
Early research (Phase 1)Ended earlyNCT01174199
What this trial is testing

Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateHormone-resistant Prostate Cancer+2 more
Roswell Park Cancer Institute 13
Testing effectiveness (Phase 2)Study completedNCT02499835
What this trial is testing

Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Soft Tissues+4 more
University of Wisconsin, Madison 66
Not applicableLooking for participantsNCT04775355
What this trial is testing

Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer

Who this might be right for
Stage I Prostate Cancer AJCC v7Stage II Prostate Cancer AJCC v7Stage IIA Prostate Cancer AJCC v7+3 more
City of Hope Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT00003717
What this trial is testing

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
St. Barnabas Medical Center 17
Large-scale testing (Phase 3)Active Not RecruitingNCT04455750
What this trial is testing

A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
Alliance for Clinical Trials in Oncology 61
Not applicableStudy completedNCT01992016
What this trial is testing

A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine

Who this might be right for
Adenocarcinoma of the ProstateBone MetastasesSoft Tissue Metastases+4 more
University of Colorado, Denver 11
Testing effectiveness (Phase 2)Ended earlyNCT00348816
What this trial is testing

Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer

Who this might be right for
Prostate Cancer
The University of Texas Health Science Center at San Antonio 21
Testing effectiveness (Phase 2)Study completedNCT03707184
What this trial is testing

Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone

Who this might be right for
Metastatic Prostate CarcinomaProstate Carcinoma Metastatic in the BoneStage IV Prostate Cancer
University of Utah 17
Large-scale testing (Phase 3)Study completedNCT00004071
What this trial is testing

Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
Pfizer
Testing effectiveness (Phase 2)Study completedNCT00331344
What this trial is testing

Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Ended earlyNCT00482274
What this trial is testing

Docetaxel in Treating Patients With Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 3
Testing effectiveness (Phase 2)Study completedNCT00012142
What this trial is testing

CCI-779 in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00003682
What this trial is testing

Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 160
Testing effectiveness (Phase 2)Looking for participantsNCT05168618
What this trial is testing

Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
University of Utah 33
Next Page